Regardless, as oxcarbazepine carries the risk of severe skin reactions, testing for the high-risk HLA-B*1502 allele in patients with relevant ancestry (i.e., genetically at-risk populations) would be beneficial (30). The gene discussed is HLA-B; the disease is skin reaction.